OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Michael Hiltensperger, Thomas Korn
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 8, Iss. 1, pp. a029637-a029637
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Role of IL-6 in the commitment of T cell subsets
Thomas Korn, Michael Hiltensperger
Cytokine (2021) Vol. 146, pp. 155654-155654
Open Access | Times Cited: 78

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders
Franz Felix Konen, Nora Möhn, Torsten Witte, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103312-103312
Open Access | Times Cited: 31

An overall view of the most common experimental models for multiple sclerosis
Simona Dedoni, María Scherma, Chiara Camoglio, et al.
Neurobiology of Disease (2023) Vol. 184, pp. 106230-106230
Open Access | Times Cited: 31

Noncoding RNAs in multiple sclerosis
Xuan Yang, Yuzhang Wu, Bei Zhang, et al.
Clinical Epigenetics (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 55

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
Tobias Brummer, Tobias Ruck, Sven G. Meuth, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 34

Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis
David Baker, Gareth Pryce, Sandra Amor, et al.
Brain (2018) Vol. 141, Iss. 10, pp. 2834-2847
Open Access | Times Cited: 46

Unraveling the role of γδ T cells in inflammatory bowel disease: Development and prevention strategies
Ana María Múnera-Rodríguez, Camila Leiva-Castro, Pedro Chacón, et al.
International review of cell and molecular biology (2025)
Closed Access

The Role of IL-23 in the Development of Inflammatory Diseases
Mario García‐Domínguez
Biology (2025) Vol. 14, Iss. 4, pp. 347-347
Open Access

The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Ali Maisam Afzali, Thomas Korn
Seminars in Immunology (2025) Vol. 78, pp. 101947-101947
Open Access

Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration
Xinli Niu, Hongzhen Sang, Junpeng Wang
The Journal of Nutritional Biochemistry (2020) Vol. 89, pp. 108560-108560
Closed Access | Times Cited: 31

miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases
Junxia Huang, Xinzhi Xu, Ji Yang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24

Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39+Treg cell subsets in response to myelin antigen in multiple sclerosis patients
Priscila M. Sacramento, Marisa C. Sales, Taissa de Matos Kasahara, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 17

Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state
Davide Mangani, Ayshwarya Subramanian, Linglin Huang, et al.
Immunity (2024)
Closed Access | Times Cited: 3

Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?
Louisa Nitsch, Linda Schneider, Julian Zimmermann, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 22

Evolved to protect, designed to destroy: IL‐17‐producing γδ T cells in infection, inflammation, and cancer
Rasmus Agerholm, Vasileios Bekiaris
European Journal of Immunology (2021) Vol. 51, Iss. 9, pp. 2164-2177
Open Access | Times Cited: 22

On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells
Georgios Ntolkeras, Chrysanthi Barba, Αthanasios Mavropoulos, et al.
Immunologic Research (2019) Vol. 67, Iss. 4-5, pp. 310-324
Closed Access | Times Cited: 25

An IL-23-STAT4 pathway is required for the proinflammatory function of classical dendritic cells during CNS inflammation
Nada S. Alakhras, Wenwu Zhang, Nicolas Barros, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 32
Closed Access | Times Cited: 2

The CTRP3-AdipoR2 Axis Regulates the Development of Experimental Autoimmune Encephalomyelitis by Suppressing Th17 Cell Differentiation
Masanori A. Murayama, Hsi-Hua Chi, Mako Matsuoka, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14

Th17/IL-17 Axis in HTLV-1-Associated Myelopathy Tropical Spastic Paraparesis and Multiple Sclerosis: Novel Insights into the Immunity During HAMTSP
Mohammadreza Shafiei, Sayed‐Hamidreza Mozhgani
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3839-3854
Closed Access | Times Cited: 4

GV‐971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities
Xinying Yang, Zhongheng Zhangyi, Aisong Yu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 1

Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes
Hans von Faber, Dunja Kurtoic, Gurumoorthy Krishnamoorthy, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 9

Immunoregulatory Functions of Nuclear Receptors: Mechanisms and Therapeutic Implications
Linjie Zhao, Ryan C. Gimple, Zhengnan Yang, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 31, Iss. 2, pp. 93-106
Closed Access | Times Cited: 7

B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic — when immunosuppression meets infection?
Marcin P. Mycko
Neurologia i Neurochirurgia Polska (2020) Vol. 54, Iss. 6, pp. 490-501
Open Access | Times Cited: 7

Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis
Goran Stegnjaić, Antonios D. Tsiailanis, Milica Lazarević, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8770-8770
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top